Studies have shown that increasing IL-10 serum concentration to a certain level can enhance the anti-tumor effect of CD8+ T cells, which has been verified in various solid tumors such as pancreatic cancer, lung cancer, and kidney cancer [54]. The gene discussed is CD8A; the disease is lung carcinoma.